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Microreview
Yersinia effectors target mammalian 
signalling pathways
focal adhesion complexes within the cell at points of
contact with bacteria, although this has not been demon-
strated conclusively. The formation of these focal adhesion
complexes coupled with signalling events, including 
the tyrosine phosphorylation of proteins in these com-
plexes, results in rearrangements in the actin cytoskeleton
via the activation of the Rho family of GTPases, which
includes Rho, Rac and Cdc42 (Aspenstrom, 1999a;
Schoenwaelder and Burridge, 1999; Chimini and Chavrier,
2000). Activation of the Rho GTPases induces their inter-
actions with downstream signalling effectors that are
involved in actin organization (Aspenstrom, 1999b). These
proteins are ideal targets for bacterial virulence factors, as
inactivation of these signalling networks would block
phagocytosis and allow the survival of the bacteria.
The inflammatory cytokines, including tumour necrosis
factor a (TNFa), interleukin-8 (IL-8) and interleukin-1 (IL-
1), are involved in activation of the adaptive immune
response, macrophage activation and inflammation. Reg-
ulation of these cytokines is controlled at the transcrip-
tional level via transcription factors including NF-kB, the
cyclic AMP-responsive element-binding protein (CREB)
and AP-1. The NF-kB transcription factor is held in the
cytoplasm through interaction with the protein IkB (Karin,
1999; Mercurio and Manning, 1999). Translocation of NF-
kB to the nucleus requires the destruction of bound IkB,
which occurs through phosphorylation of IkB by the IkB
kinase complex (IKK) and subsequent ubiquitination of
IkB (Karin, 1999). CREB and AP-1 transcription factors
are activated through phosphorylation via mitogen-
activated protein (MAP) kinase signalling cascades
(Pearson et al., 2001). One can envisage that inhibition
of these signalling cascades, perhaps through effects on
these regulatory factors, would be an ideal mechanism for
a pathogen to use in order to escape the host inflamma-
tory response.
Yersinia infection
Yersinia pestis causes bubonic plague, whereas Yersinia
pseudotuberculosis and Yersinia enterocolitica both
cause gastrointestinal disorders. Enteropathogenic
Yersinia (Y. pseudotuberculosis and Y. enterocolitica)
enter the lymphoid system of their hosts via passage
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Summary
Animals have an immune system to fight off chal-
lenges from both viruses and bacteria. The first line
of defence is innate immunity, which is composed of
cells that engulf pathogens as well as cells that
release potent signalling molecules to activate an
inflammatory response and the adaptive immune
system. Pathogenic bacteria have evolved a set of
weapons, or effectors, to ensure survival in the host.
Yersinia spp. use a type III secretion system to
translocate these effector proteins, called Yops, into
the host. This report outlines how Yops thwart the 
signalling machinery of the host immune system.
Introduction
Innate immunity and signalling
Innate immunity is the first line of defence against bacte-
rial and viral infection (for a review of innate immunity, see
Medzhitov and Janeway, 2000). The cells involved in 
the immune response use a wide variety of signalling 
cascades to activate processes such as phagocytosis,
cytokine production and release and production of reac-
tive oxygen species. In addition to eliminating pathogens,
the innate immune system activates the adaptive immune
response through the presentation of foreign peptides to
T cells.
Phagocytosis is an essential component of the innate
immune system (May and Machesky, 2001). Rearrange-
ment of the actin cytoskeleton during phagocytosis is
mediated by the recruitment of proteins that function in
actin rearrangement; these include paxillin, p130Cas and
focal adhesion kinase (FAK) (Greenberg et al., 1990;
1993; Allen and Aderem, 1996). These proteins may form
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through M cells (microfold cells), which are specialized
cells that take up foreign antigens, in intestinal Peyer’s
patches (Autenrieth and Firsching, 1996). Recognition 
of Yersinia by M cells is mediated via b1 integrins on the
M-cell plasma membrane and the invasin protein of
Yersinia (Marra and Isberg, 1997; Clark et al., 1998).
Once Yersinia has penetrated the M cells, it can localize
in the lymphoid tissue of its host.
The recently sequenced genome of Y. pestis (Parkhill
et al., 2001) suggests that many of the genes that Yersinia
uses during infection and invasion, including adhesins,
secretion systems and insecticidal toxins, have been
acquired from other bacteria and viruses. Furthermore, 
all three pathogenic species of Yersinia harbour an 
extrachromosomal plasmid of 70 kb that is essential for
virulence (Portnoy and Martinez, 1985). This plasmid con-
tains the genes of a type III secretion system, a translo-
cation apparatus highly conserved among pathogenic
Gram-negative bacteria (for a review, see Cornelis, 1998).
This secretion system is responsible for the translocation
of the Yersinia effectors, termed Yops, into the host cell.
Once inside the host cell, Yops carry out disruption of sig-
nalling cascades that activate the processes of phagocy-
tosis, cytokine release and respiratory burst. Six Yop
effectors have been identified (YopH, YopE, YopJ/P,
YpkA/YopO, YopT and YopM). Some of these effectors are
known to function in the downregulation of critical sig-
nalling cascades of the immune system (Fig. 1). The activ-
ities of these effectors and the pathways they target are
described below.
YopH
YopH was identified as an essential Yersinia virulence
factor that inhibits macrophage phagocytosis (Bolin 
and Wolf-Watz, 1988; Rosqvist et al., 1988). The 51 kDa
YopH protein contains C-terminal sequences similar to 
the protein tyrosine phosphatase (PTPase) superfamily
(Guan and Dixon, 1990). These sequences include
residues located within the active-site (D(X)nHC(X)5R) of
the PTPases (Fig. 2A). YopH catalyses phosphate hydrol-
ysis from tyrosine-phosphorylated peptides and proteins
(Guan and Dixon, 1990). Bliska et al. (1991) demon-
strated that bacterially produced YopH can translocate
into macrophages. The translocation requires cell contact
between the bacteria and the macrophage. Once inside
the mammalian cell, the bacterial phosphatase is capable
of dephosphorylating host phosphotyrosine-containing
proteins, leading to a reduction in invasin-mediated 
bacterial engulfment. Furthermore, the catalytic activity of
YopH is necessary for its role in the virulence of Yersinia
(Bliska et al., 1991), suggesting that the targets of YopH
within the host cell are important in regulating
macrophage signalling during the process of phagocyto-
sis during infection. YopH dephosphorylates p130Cas,
focal adhesion kinase (FAK), paxillin and the Fyn-binding
protein (FBP), thereby inhibiting the formation of focal
adhesion complexes (Fig. 1) (Black and Bliska, 1997;
Persson et al., 1997; Black et al., 1998; Hamid et al.,
1999). YopH bears a similar three-dimensional structure
to the mammalian PTPases (Stuckey et al., 1994), 
suggesting that YopH most probably catalyses tyrosine
phosphate hydrolysis via a similar mechanism to the
mammalian PTPases.
It is well established that tyrosine phosphorylation plays
a role in respiratory burst induction (Yamaguchi et al.,
1995). Therefore, it is not surprising that YopH down-
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Fig. 1. The Yersinia effectors target multiple
signalling pathways. The Yop effectors of
Yersinia are translocated into the host cell via
a type III secretion system. Once inside the
host cell, each of the effectors targets
signalling pathways to ensure survival of the
bacteria within its host. YopH, a protein
tyrosine phosphatase, dephosphorylates
p130Cas, FAK and paxillin, causing disruption
of focal adhesion complexes and inhibition of
phagocytosis. YopE, a Rho GTPase-activating
protein (GAP), inactivates the Rho family of
GTPases, resulting in altered actin
cytoskeleton. YpkA, a protein serine/threonine
kinase, disrupts the actin cytoskeleton. YopJ,
a putative cysteine protease, disrupts multiple
signalling pathways, resulting in inactivation of
MAP kinase and NF-kB and, ultimately,
apoptosis and inhibition of cytokine
production. YopT is a protein of unknown
function that causes a modification of the Rho
family of GTPases, presumably to alter the
actin cytoskeleton. YopM, a protein of
unknown function, contains leucine-rich
repeats, which are presumably used to bind
to host proteins.
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regulates signalling cascades required for the activation
of Fc-mediated respiratory burst in macrophages (Bliska
and Black, 1995) and neutrophils (Ruckdeschel et al.,
1996). This inhibition of respiratory burst induction 
by Yersinia requires the tyrosine phosphatase activity 
of YopH (Bliska and Black, 1995). However, Zymosan-
induced oxidative burst inhibition by Y. enterocolitica in
murine bone marrow-derived macrophages was not
dependent on the catalytic activity of YopH (Green et al.,
1995). These results suggest a redundancy in Yop func-
tion in the inhibition of zymosan-induced oxidative burst.
The proteins that YopH dephosphorylates to inhibit induc-
tion of the Fc-mediated respiratory burst have not been 
identified.
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Fig. 2. Sequence alignments and structural diagrams of the Yop effectors and their homologues.
A. YopH harbours a protein tyrosine phosphatase (PTPase) domain at the carboxy-terminus, which is represented by the presence of the
catalytic D(X)28HC(X)5R motif.
B. The GAP domains of YopE, SptP and ExoS show significant similarity to each other. However, this domain differs from any of the known
eukaryotic GAP domains, except for the presence of the mammalian Rho GAP consensus motif GxxRxSG (in red). The arginine plays a
critical catalytic role in GTP hydrolysis activity.
C. Sequence comparison of YopJ, adenovirus protease (AVP) and Ulp1, a yeast ubiquitin-like protein protease. YopJ shows significant
similarity to AVP within the protease domain and shares the catalytic triad including His (in yellow), Asp/Glu (in green) and Cys (in red) for
protease activity and an invariant Gln (in blue) located in the oxyanion hole of both AVP and Ulp1.
D. Sequence alignment of the kinase domain VI, VII and VII between YpkA and canonical Ser/Thr kinase (PKC1, CKIIa and Akt1) and Tyr
kinase (EGFR, c-ABL and Ack). Invariant residues essential for kinase activity, including the catalytic Asp and Asn, Asp-Phe-Gly chelating Mg2+
and stabilization loop Ala-Pro-Glu, are highlighted in yellow. The lysine (in blue) within the catalytic loop renders YpkA to be a Ser/Thr kinase.
The lysine (blue) or arginine (green) is believed to play a role in stabilization of the transition-state intermediate during catalysis.
E. Representation of the leucine-rich repeat (LRR)-containing type III secreted virulence factors from Yersinia (YopM), Shigella (IpaH family),
Salmonella (SspHs and Slrp) and symbiotic Rhizobium (Y4FR) and Bradyrhizobium (ID431). LRR is represented by the blue box. The
numbers after the diagram indicate the number of LRRs present in each gene or gene family.
F. YopT exhibits sequence similarity to the C-terminus of surface antigen (p76) from Haemophilus somnus, filamentous haemagglutinin-like
protein Lsp2 from Haemophilus ducreyi and PfhB2 from Pasteurella multocida. Several conserved residues that may suggest catalytic activity
are highlighted in blue.
YopH has recently been implicated in inhibiting the
adaptive immune response. The phosphatase activity of
YopH was shown to be essential for suppressing both 
T-cell cytokine production and expression of the B-cell 
co-stimulatory receptor B7.2 (Yao et al., 1999). This
downregulation of T-cell and B-cell signalling was most
probably caused by dephosphorylation of tyrosine
residues on proteins in both the T-cell receptor and the B-
cell receptor complexes (Yao et al., 1999). These data
suggest that Yersinia may function to inhibit both innate
and adaptive immunity, although there is no evidence for
inhibition of the adaptive immune response by Yersinia in
vivo.
It should also be noted that other pathogenic bacteria
produce a protein tyrosine phosphatase effector. 
Salmonella spp. produce the protein SptP, which contains
a YopE-like domain (discussed below) fused to a YopH-like
domain (Kaniga et al., 1996). However, the substrates of
the phosphatase domain of SptP have not been identified.
YopE
The 23 kDa YopE was one of the earliest identified 
Yop effectors (Forsberg and Wolf-Watz, 1988) and is an
essential virulence determinant. Targeting YopE into both
epithelial cells and macrophages leads to a cytotoxic
response, in which cells round up and contract away from
the extracellular matrix (Rosqvist et al., 1990). Microin-
jection studies show that this effect results from disrup-
tion of the actin microfilament network (Rosqvist et al.,
1991a). Mutation of YopE impairs the ability of Yersinia
to resist phagocytosis (Rosqvist et al., 1990; Ruckdeschel
et al., 1996), suggesting that YopE contributes to the
antiphagocytic capability of Yersinia.
YopE contains a carboxyl-terminal effector domain
(Sory et al., 1995; Schesser et al., 1996) that shares a
high degree of similarity to the amino-terminal domain of
exoenzyme S (ExoS) of Pseudomonas aeruginosa and
SptP from Salmonella typhimurium (Fig. 2B). Fu and
Galan (1999) noted that this domain harbours a con-
served ‘arginine finger’ used by mammalian Rho GTPase-
activating proteins (GAP) for catalysis (Fig. 2B) and also
demonstrated that the amino-terminal half of SptP has
GAP activity towards Rac and Cdc42 in vitro. Recently,
YopE and ExoS were also demonstrated to possess 
GAP activity towards Rho family GTPases (RhoA, Rac 
and Cdc42) (Fig. 1) (Goehring et al., 1999; Black and
Bliska, 2000; Von Pawel-Rammingen et al., 2000). 
Activation of Rho GTP-binding proteins is a pivotal 
signalling event connecting receptor activation to
cytoskeletal reorganization during phagocytosis in pro-
fessional and non-professional phagocytic cells (Chimini
and Chavrier, 2000; May and Machesky, 2001). The
mechanism of inhibition of phagocytosis by YopE results
from its Rho GAP activity, as substitution of the essential
arginine with alanine destroys the ability of YopE to inter-
fere with phagocytosis in cultured HeLa cells (Black and
Bliska, 2000). In addition, Yersinia strains harbouring only
the mutant version (R144A) of YopE are avirulent in a
mouse infection model (Black and Bliska, 2000). The
crystal structures of the GAP domain of ExoS and SptP
(Stebbins and Galan, 2000; Wurtele et al., 2001) reveal
that this effector domain mimics the mammalian Rho GAP
domain by providing a similar interface to contact Rho
GTPases and positioning the catalytic arginine in a posi-
tion that allows for stabilization of the transitionstate
intermediate. This structure bears no similarity to the
structure of the Rho GAPs (Stebbins and Galan, 2000),
suggesting that the bacterial and mammalian GAP activ-
ities arose independently.
Unlike SptP, YopE exhibits no preference towards
RhoA, Rac and Cdc42 as its substrate in vitro (Black 
and Bliska, 2000). It will be interesting to unravel which
Rho GTPase is preferred under physiological conditions.
RhoA and Rac are the two most probable candidates 
documented in the literature. RhoA is the small GTPase
switch controlling stress fibre formation in fibroblasts as
well as in macrophages (Hall, 1998). The morphology of
actin stress fibre disruption induced by YopE implies that
RhoA might be the target of YopE in vivo (Rosqvist et al.,
1991b). This is substantiated by the observation that over-
expression of RhoAV14, an activated form of RhoA, 
prevents the cytotoxic phenotype induced by YopE in 
cultured HeLa cells (Black and Bliska, 2000). In addition,
overexpression of molecules involved in the yeast Rho1
pathway, the RhoA homologue in yeast, is able to coun-
teract the growth inhibition phenotype in yeast caused by
YopE (Von Pawel-Rammingen et al., 2000). However, this
hypothesis was challenged by recent morphology studies
in cultured endothelial cells (Andor et al., 2001). Mem-
brane ruffling triggered by Cdc42-dependent Rac activa-
tion is abrogated by YopE translocation, suggesting that
YopE selectively targets Rac (Andor et al., 2001). This
result is consistent with the observation that overexpres-
sion of Rac1V12, an active form of Rac1, interferes with
the antiphagocytic activity of YopE in cultured HeLa cells
(Black and Bliska, 2000). Taken together, one can spec-
ulate that YopE might target both RhoA and Rac for dif-
ferent purposes. More information about the substrate of
YopE in vivo awaits further analysis, including the high-
resolution crystal structure of YopE and the precise cellu-
lar localization of YopE.
Recent studies have demonstrated that selective acti-
vation of RhoA, Rac and Cdc42 is required in different
phagocytosis processes (Chimini and Chavrier, 2000;
May and Machesky, 2001), suggesting that the action of
© 2002 Blackwell Science Ltd, Cellular Microbiology, 4, 201–211
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YopE would allow Yersinia to inhibit these multiple
processes. Indeed, Y. pseudotuberculosis and Y. entero-
colitica are able to inhibit b1 integrin-mediated uptake 
in cultured epithelial cells (Black and Bliska, 2000). Y.
pseudotuberculosis is capable of inhibiting Fc receptor-
mediated phagocytosis in professional phagocytic cells
(Fallman et al., 1995). Given that Yersinia-infected HeLa
cells lose the ability to phagocytose not only Yersinia
itself, but also other microorganisms (Mecsas et al.,
1998), Yersinia might also antagonize complement recep-
tor (b2 integrin)-mediated phagocytosis. Studies on the
mechanism used by different phagocytosis pathways and
identification of physiological targets of YopE will aid in the
understanding of not only which GTPases are involved in
distinct phagocytosis events, but also how YopE acts to
inhibit these processes.
As stated earlier, Yersinia encode for a type III secre-
tion apparatus that is essential for the translocation of 
the Yops into the host cell (Cornelis, 1998). The structure 
of this apparatus from Shigella and Salmonella resembles
a needle, which probably functions to allow transport
across the inner and outer membranes of the bacteria 
and into the cytoplasm of the host cell (Blocker et al.,
1999; Kubori et al., 2000; Tamano et al., 2000). 
One model suggests that the Yops function in part to
prevent a pore from forming in the host cell plasma 
membrane resulting from insertion of the apparatus.
Indeed, mutant strains of Yersinia defective for multiple
Yop effectors contain a higher activity of pore formation
caused by the type III secretion apparatus than Yersinia
wild-type strains (Hakansson et al., 1996a; Neyt and 
Cornelis, 1999; Tardy et al., 1999), suggesting that one or
more of the Yop effectors prevents pore formation and
lysis of the host cell. The GAP activity of YopE is essen-
tial in the prevention of pore formation (Viboud and Bliska,
2001), suggesting that pore formation requires activated
Rho GTPases and actin polymerization. These data also
suggest that the prevention of pore formation by YopE is
not simply the occupation of YopE within the pore, but
rather involves the downregulation of the Rho GTPases
within the host cell.
YopJ
The 32.5 kDa YopJ/YopP was first identified in Y. pestis
(YopJ) (Straley and Bowmer, 1986) and later in Y.
pseudotuberculosis and Y. enterocolitica (YopP) (Cornelis
et al., 1987). YopJ was first shown to be dispensable for
the virulence of Y. pseudotuberculosis (Galyov et al.,
1994). However, it was later demonstrated that the apop-
tosis induced by YopJ aids in the establishment of a sys-
temic infection in vivo (Monack et al., 1998). So far, YopJ
is the only Yop effector that has been shown to have an
anti-inflammatory role and to be responsible for the induc-
tion of apoptosis in macrophages.
After the transient induction of multiple signalling path-
ways (MAPK and NF-kB pathway) by lipopolysaccharide
(LPS), Yersinia infection results in a severe inhibition of
multiple MAPK signalling pathways (Erk, JNK and p38) in
macrophages (Ruckdeschel et al., 1997a). Translocation
of YopJ through the type III secretion machinery is
required for this inhibition (Boland and Cornelis, 1998;
Palmer et al., 1998). In addition, YopJ alone is sufficient
to cause downregulation of multiple MAPK kinases
(Fig. 1) (Palmer et al., 1999). YopJ can also block NF-kB
activation through the inhibition of IkB degradation and
subsequent NF-kB translocation in both macrophages
and epithelial cells (Ruckdeschel et al., 1998; 2001;
Schesser et al., 1998). It was difficult to understand how
one protein could simultaneously block a multiplicity of
signalling pathways that have no apparent common com-
ponents. Orth et al. (1999) made the key observation that
YopJ can bind to multiple members of the MAPK kinase
superfamily, including MKKs and IKKb, and suppress their
activation. The interaction between YopJ and IKKb
was also confirmed by co-immunoprecipitation from
macrophages (Denecker et al., 2001; Ruckdeschel et al.,
2001).
Yersinia infection causes macrophage apoptosis
(Ruckdeschel et al., 1997b) as well as the inhibition 
of cytokine production and an inflammatory response
(Nakajima and Brubaker, 1993; Beuscher et al., 1995;
Schulte et al., 1996). These processes allow the pathogen
to survive and multiply extracellularly in the host lymphoid
tissue. Studies on the function of YopJ have offered
insights into the mechanism underlying the inhibition of
cytokine production. YopJ was shown to be necessary for
the inhibition of TNFa and IL-8 production (Boland and
Cornelis, 1998; Palmer et al., 1998; Schesser et al.,
1998). Inactivation of multiple MAPK pathways and the
NF-kB pathway parallels the decrease in TNFa produc-
tion (Ruckdeschel et al., 1997a). Considering that the
TNFa and IL-8 promoters harbour NF-kB and AP-1
binding sites (Roebuck, 1999; Liu et al., 2000), and
MAPKs and NF-kB signals converge to the transcription
factors AP-1 and NF-kB, inhibition of cytokine production
is probably the result of disruption of MAPK and NF-kB
activation.
YopJ is the only Yop effector required for the induction
of apoptosis in murine macrophages (Mills et al., 1997;
Monack et al., 1997). However, induction of apoptosis
seems to be independent of the role of YopJ in perturb-
ing signalling pathways, as YopJ does not induce apop-
tosis in fibroblasts even though it disrupts the same
signalling pathways within fibroblasts. Recent studies
suggest that the apoptotic signalling upstream of Bid
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cleavage and cytochrome c release, presumably through
caspase 8 activation, is responsible for the YopJ-induced
apoptosis in macrophages (Denecker et al., 2001).
Macrophage apoptosis caused by YopJ most probably
results from inactivation of NF-kB, as inhibition of NF-kB
leads the macrophage to undergo apoptosis (Pagliari
et al., 2000).
Recent reports from Orth et al. (2000) revealed that
YopJ may function as a cysteine protease. The observa-
tion arose from the finding that the predicted secondary
structure of YopJ was similar to the observed secondary
structure determined from the X-ray structure of the ade-
novirus protease. Furthermore, critical catalytic residues
of protease activity were conserved in both YopJ and the
adenovirus protease (Fig. 2C). Mutation of the predicted
catalytic residues required for cysteine protease activity
abolished the ability of YopJ to disrupt MAPK signalling
pathways (Orth et al., 2000). This hypothesis was con-
firmed further by the inability of mutants in the predicted
catalytic residues of AvrBst, a predicted YopJ homologue
in the plant pathogen Xanthomonas campestris, to induce
a plant hypersensitive response (Orth et al., 2000). These
authors also suggest that YopJ might be a ubiquitin-
like protein protease based on the sequence similarity
between YopJ and Ulp1 (Fig. 2C), a yeast ubiquitin-like
protein protease (Li and Hochstrasser, 1999). These data,
taken together with the initial observations that YopJ can
block MAPK activation via phosphorylation (Orth et al.,
1999), suggest that ubiquitin-like protein modification
plays an unidentified regulatory role in MAPK signalling.
A growing family of ubiquitin-like proteins has recently
been shown to be involved in modulating eukaryotic 
signalling pathways (reviewed by Yeh et al., 2000). 
The suggestion that YopJ inhibits signalling by the
removal of ubiquitin-like proteins casts new light on 
deciphering the mechanism of Yersinia pathogenesis 
as well as eukaryotic signalling pathways. Importantly,
however, demonstration of in vitro protease activity by
YopJ and identification of the substrate(s) of YopJ are
needed.
YopJ shows similarity to other type III secreted effec-
tors including AvrA from Salmonella, AvrRxv, AvrBst, XopJ
and AvrXv4 from X. campestris, AvrPpiG1and ORF5 from
Pseudomonas syringae, ORFB from Erwinia amylovora
and y4lo from Rhizobium. Thus, YopJ may function by a
common catalytic mechanism across both animal and
plant kingdoms (Orth et al., 2000). This suggests that the
signalling pathways disrupted by YopJ family effectors are
conserved in both plants and animals. Indeed, both YopJ
and AvrBst can induce apoptosis in macrophages and
plants respectively (Mills et al., 1997; Monack et al., 1997;
Orth et al., 2000). However, it has been demonstrated that
AvrA from Salmonella does not inhibit the same pathways
as YopJ (Schesser et al., 2000), suggesting that some of
the YopJ homologues may function differently mechanis-
tically. However, the similarity among the family does
suggest a common catalytic activity.
YpkA
The Yersinia protein kinase YpkA was first identified as a
secreted protein that is capable of autophosphorylation on
serine residues (Galyov et al., 1993). YpkA contains a
domain bearing similarity to the eukaryotic serine/threo-
nine protein kinases (Fig. 2D) (Galyov et al., 1993). This
study also demonstrated that YpkA is an essential viru-
lence determinant for Yersinia infection, as disruption of
the YpkA gene in Yersinia results in an avirulent strain of
bacteria in an animal model. This was the first identifica-
tion of a bacterial protein kinase playing a direct role in
virulence.
Once inside the host cell, YpkA causes a change in
morphology distinct from those mediated by YopE, in that
the cells containing YpkA round up but do not detach from
the extracellular matrix (Hakansson et al., 1996b). Fur-
thermore, YpkA is translocated to the plasma membrane
(Fig. 1) (Hakansson et al., 1996b), suggesting that the
substrates for YpkA may be localized at the plasma mem-
brane as well. Interestingly, YpkA produced by bacteria
exhibits no detectable kinase activity unless a eukaryotic
kinase activator is present. Purification of this eukaryotic
activator led to its identification as actin (Juris et al.,
2000). The C-terminus of YpkA, which is predicted to form
an amphipathic helix, is required for YpkA kinase activity
and for the interaction between YpkA and actin (Juris
et al., 2000). Interaction between YpkA and actin sug-
gested that the morphological changes induced by YpkA
might be caused by changes in the actin cytoskeleton.
Indeed, YpkA induces disruption of actin stress fibres in
HeLa cells in transient transfection experiments (Fig. 1)
(Juris et al., 2000). Disruption of the actin cytoskeleton by
YpkA might be mediated by its ability to interact with 
the small GTPase RhoA, which plays an important role 
in actin dynamics within the cell (Barz et al., 2000;
Dukuzumuremyi et al., 2000). Although actin can be
phosphorylated in vitro (Juris et al., 2000), the in vivo sub-
strate is not clear. Phosphorylation of actin by YpkA is not
likely to be physiologically significant because of the
abundance of actin in a cell. YpkA most probably func-
tions by phosphorylating proteins that are important in the
regulation of the actin cytoskeleton within the host cell.
The substrates of YpkA probably have an important role
in RhoA signalling. Through its ability to disrupt the actin
cytoskeleton, YpkA may have an effect on the ability of a
macrophage to phagocytose Yersinia and to move to
areas of infection.
It is intriguing that several pathogenic species of 
bacteria encode proteins with domains that resemble
© 2002 Blackwell Science Ltd, Cellular Microbiology, 4, 201–211
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eukaryotic-like serine/threonine protein kinase domains
(Leonard et al., 1998; Avenue-Gay and Everett, 2000).
These proteins control development and stress re-
sponses within the bacteria. Only YpkA and a protein
kinase from Pseudomonas aeruginosa have been 
shown to be essential virulence determinants (Galyov
et al., 1993; Wang et al., 1998). Yersinia, and other path-
ogenic bacteria may use these eukaryotic-like protein
kinases to tip the balance of signalling cascades within
their hosts by phosphorylating endogenous substrates
that regulate immune responses to levels that completely
shift the state of those signalling cascades in favour of
bacterial survival.
YopM
The Yersinia protein YopM is a 41 kDa protein that is a
necessary virulence determinant of Y. pestis (Leung et al.,
1990). YopM is composed almost entirely of sequences
resembling leucine-rich repeats (LRRs). The LRR domain
is found in a diverse number of proteins, including 
the RNase inhibitor, the Toll receptors, proteoglycans 
and platelet glycoproteins (for a review, see Kobe and
Deisenhofer, 1994). This domain is believed to be a
protein–protein interaction motif functional in a multitude
of signalling pathways both within the cell and in the extra-
cellular milieu.
The diversity of signalling pathways governed by LRR-
containing proteins has made it difficult to ascertain the
exact pathways that YopM may affect. Initial characteri-
zation of YopM demonstrated its ability to interact 
with thrombin and inhibit thrombin-induced platelet aggre-
gation (Reisner and Straley, 1992), suggesting that 
YopM may actually function in the extracellular environ-
ment of the host. However, YopM has also been 
shown to be translocated into macrophages via the type
III secretion apparatus (Boland et al., 1996), making 
the exact location of YopM during Yersinia infection 
controversial. Recent studies have shown that YopM is
not only translocated into HeLa cells during Yersinia infec-
tion, but also localizes to the nucleus of HeLa cells, traf-
ficking via a vesicle-associated pathway (Skrzypek et al.,
1998).
Other LRR-containing proteins have been identified in
both pathogenic and symbiotic bacteria. These include
the IpaH family from Shigella flexneri, SspH 1, SspH 
2 and Slrp from Salmonella typhimurium, y4fr from 
Rhizobium and ID431 from Bradyrhizobium (Fig. 2E). The
functions of all these LRR-containing proteins are un-
known. These proteins may have been acquired by both
pathogenic and symbiotic bacteria to thwart similar 
pathways within the host. The structure of YopM reveals
a parallel b-sheet on its concave face, which is typical of
the solved structures of other LRR-containing proteins
(Evdokimov et al., 2001). However, in other LRR-
containing proteins, such as the RNase inhibitor (Kobe
and Deisenhofer, 1993) and internalin B (Marino et al.,
1999), the convex surface is typically helical in structure,
whereas on YopM, this face contains an extended struc-
ture (Evdokimov et al., 2001). This may be caused by the
short length of the LRR of YopM. Furthermore, the YopM
structure suggests that it forms a tetramer, which creates
a channel with a pore of 35 Å (Evdokimov et al., 2001).
YopT
The function of YopT is largely unknown; however,
translocation of YopT into host cells results in cell round-
ing and disruption of cytoskeleton structure, a cytotoxic
response resembling that of YopE (Iriarte and Cornelis,
1998; Zumbihl et al., 1999; Boyd et al., 2000). YopT is
secreted in lower amounts than YopE, although both
effectors appear to function by altering the host cytoskele-
ton structures (Iriarte and Cornelis, 1998). Why does
Yersinia have two cytotoxins (YopT and YopE) to abrogate
cytoskeleton structures? The answer to this question is
unknown, although there are several possibilities. Unlike
YopE mutants, YopT mutants colonize intestinal Peyer’s
patches as in wild type (Iriarte and Cornelis, 1998), sug-
gesting that YopT and YopE may have different roles in
altering cytoskeleton structure during the course of a
Yersinia infection. Similarly, in in vitro experiments, YopE
mutant strains of Y. pseudotuberculosis exhibit a signifi-
cant decrease in cytotoxicity (Rosqvist et al., 1991b),
whereas YopT mutant strains of Y. enterocolitica are as
cytotoxic as the wild-type strains (Hartland et al., 1994;
Iriarte and Cornelis, 1998). Thus, YopT and YopE may
affect different signalling pathways to synergize the cyto-
toxic effect and secure the survival of the pathogen in 
lymphoid tissues. Recently, Zumbihl et al. (1999) demon-
strated that infection of a YopT strain causes an uniden-
tified modification of RhoA (Fig. 1). The GTPase shows
an acidic shift in its pI after infection with YopT. Modifica-
tion of RhoA by YopT may inhibit its ability to alter the
cytoskeleton during phagocytosis, allowing for the sur-
vival of Yersinia.
Sequence comparisons show that YopT is similar to the
C-terminus of surface antigen p76 from Haemophilus
somnus and a small portion of the filamentous 
haemagglutinin-like protein from Haemophilus ducreyi
called Lsp1 and Lsp2 as well as PfhB1 and PfhB2 from
Pasteurella multocida (Fig. 2F). The function of these 
proteins is unknown. The several conserved residues
among these proteins suggest a similar catalytic activity.
However, none of the proteins similar to YopT has been
shown to modify RhoA. Further studies on the function of
the YopT-like domain in these proteins will also provide
additional insights into YopT pathogenesis.
© 2002 Blackwell Science Ltd, Cellular Microbiology, 4, 201–211
Concluding remarks
The Yersinia species of bacteria contain six characterized
Yop effectors to disrupt vital signalling cascades that are
required for innate immunity. Studies on the functions of
these effectors have revealed the signalling pathways
they target and have also shed light on novel signalling
pathways used by the host to induce an immune
response. Yersinia has probably acquired some (or all) of
its effectors via horizontal gene transfer between bacteria
and fine tuned these effectors to regulate signalling path-
ways within its host. Those signalling pathways targeted
by the effectors play crucial roles in the elimination of
pathogens. Identification of the functions of new effectors,
as well as the targets or substrates of these effectors, will
aid in the understanding of bacterial pathogenesis as well
as innate immunity.
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